February’s top news stories
Eidos Therapeutics commenced a pivotal Phase III clinical trial of its investigational small molecule AG10 for the treatment of transthyretin…
Roundup
January’s top news stories
Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III TITAN trial investigating Erleada (apalutamide) in combination with androgen…
2018: The year’s biggest Drug Development Technology stories
The US National Institutes of Health (NIH) has provided funding for a clinical trial to examine the effectiveness of male…